With the improvement of people’s living standards, medical checkups have become an annual necessity for many people, and with them, various diseases that do not easily cause discomfort have entered people’s view, of which hepatic hemangioma is a typical representative. Hepatic hemangiomas are the most common benign tumors of the liver, occurring between the ages of 30 and 50, and are more common in women. Hepatic hemangiomas usually occur in childhood and are found during adult physical examinations and are usually solitary, or in a few cases, multiple. Hepatic hemangiomas are usually asymptomatic, especially when they are small. When the partial hepatic hemangioma is larger or grows to the edge of the liver, symptoms such as persistent vague abdominal pain, fullness after meals, indigestion, etc. may occur, and can be life-threatening if it ruptures and bleeds spontaneously or if external impact causes bleeding. In daily life, hepatic hemangioma should be a disease that people both love and hate. Why do you say love it? Because in general medical examination, it is difficult to distinguish hepatic hemangioma from liver cancer, maybe ultrasound can only find that there is a tumor in the liver, but it is not easy to distinguish benign or malignant, which makes people worried; and after further examination, the moment we get the result, the report shows that it is hepatic hemangioma, not liver cancer, at this time, a worried heart can finally return to normal! At this moment, I think I should love it to death! And then came the problem: should we treat it? How to treat it? The doctor may tell you that it is benign, don’t worry, but be careful not to break it or be careful when you fall down, it will kill you if it bleeds…treatment? Yes, but there are also risks associated with surgery, such as… and so on. I think the mood at this time has instantly hit the bottom, and you should hate it! Indeed, liver hemangioma is almost ineffective through drug treatment, and the traditional method is surgery, but because of the high risk of surgery, long recovery time after surgery, and relatively large trauma to the body, it has become the biggest problem for patients suffering from liver hemangioma: surgery is so risky, and now there is no discomfort, in case there are any complications from surgery, it is not a big loss? In fact, in recent years, the minimally invasive treatment of hepatic hemangioma has developed very rapidly, and the representative interventional treatment of hepatic hemangioma has been gradually promoted and applied, and it can be carried out skillfully in many tertiary hospitals in China, and now it has become one of the common clinical treatment methods. Interventional treatment of hepatic hemangioma is mainly divided into two kinds, one is selective hepatic artery embolization, and the other is direct percutaneous puncture sclerotherapy and drug injection. Selective hepatic artery embolization refers to piercing a rice-sized opening with a needle in the femoral artery, and then operating a catheter through it to the blood supply artery of hepatic hemangioma, and then embolizing the blood supply vessel while injecting drugs into the hepatic hemangioma through the catheter, because the drugs can inhibit and destroy the endothelial cells of blood vessels, and then after embolizing the blood supply artery, the abnormal sinusoidal thrombus formation of hepatic hemangioma can be mechanized, so that the tumor can shrink and achieve the purpose of The purpose of treatment. Direct percutaneous puncture percutaneous puncture sclerotherapy, drug injection treatment is to insert the needle directly into the hepatic hemangioma under the guidance of B ultrasound or CT, and then inject the sclerosing agent directly into the tumor, so that the tumor tissue will be fixed by dehydration and the cell protein will be coagulated and denatured, which will lead to necrosis of the tumor, fibrosis and slowly shrink and absorb, thus achieving the treatment purpose. The most important features of these two types of minimally invasive treatment for hepatic hemangioma are: small trauma: the small puncture opening only needs to be disinfected, and then a band-aid is applied to it, no need to change medication or anti-inflammatory drugs; small impact on liver function: nowadays, with the development of microcatheters and other interventional materials, liver function is sometimes basically not damaged, or only a little bit damaged, and it recovers in a few days; short hospitalization days: I think no one wants to stay in the hospital for a few more days. hospital for a few more days, and both methods can achieve this goal. A few days of postoperative liver protection drugs are usually sufficient, and the patient can be discharged soon. Low risk: Both techniques are relatively mature and are routinely performed in many tertiary care hospitals, with very low risk. To put it in layman’s terms, if you want open surgery for hepatic hemangioma, you probably have to find a senior, fairly experienced chief of surgery to do it, whereas if it’s an intervention, then you’re looking for a generally responsible attending physician! Of course, hepatic hemangioma is a benign tumor, not all of which must be treated. Treatment can be considered in the following cases: 1.hepatic hemangioma larger than 5cm, with obvious pressure symptoms or pain; 2.hepatic hemangioma adjacent to the liver envelope, with the risk of rupture; 3.hepatic hemangioma has ruptured and bleeding (this must be done, interventional embolization to stop bleeding is very effective); 4.unable to open resection or unwilling to accept open treatment; 5.hepatic hemangioma found to increase rapidly for a short time during regular review.